Fasting brings gut hormones, above all insulin, to zero ('your fasting insulin equals zero').
Original statement
فالصيام يُصفّر الهرمونات المعوية، وعلى رأسها الأنسولين، فيمنح الكبد والأمعاء فرصة الإصلاح وإخراج السموم.
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Fasting brings gut hormones, above all insulin, to zero ('your fasting insulin equals zero').
Origin
- Source status
- Archive editors
- Attribution
- Archive editors summarising Elawady's view (homepage summary; not the quote box)
- Origin
- https://eltayebat.com/
- Attribution uncertainty
- Homepage summary written by the archive operators describing Elawady's views; partly cites his 'statement of the theory' video (aEbRfVSJIOw), otherwise no video reference.
- Claimed mechanism
Insulin is only secreted in response to food in the gut.
- Claimed health effect
Insulin falls to zero during fasting
- Population concerned
Everyone
- Geographic restriction by Elawady
none found
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live!فلسفة الصيام مع السحور المحترم (Open source)
- Published
- 23 February 2026
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- ارتفاع السكر والأسيتون ؟خطر والا ده الطبيعي ؟#ضياء_العوضي (Open source)
- Published
- 23 December 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
Scientific assessment
Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
Fasting reduces insulin (and other gut hormones) to zero.
2. What is demonstrably correct?
Insulin secretion falls during fasting, which permits lipolysis and ketone body production; ketones (beta-hydroxybutyrate) become a major brain fuel in prolonged starvation (I-FAST-01). Fasting regimens can lower fasting insulin (I-FAST-05).
3. What is wrong or exaggerated?
Insulin does not fall to zero in healthy people; a low basal level persists and restrains ketone production and hepatic glucose output. When insulin truly approaches zero (type 1 diabetes), ketoacidosis develops (I-INS-08). A fasting glucose of 700 mg/dL, which Elawady mentions as compatible with 'zero insulin', is a medical emergency indicating severe insulin deficiency, not a healthy fasting state. Insulin is also not only a gut hormone; it is a pancreatic hormone released into the portal vein, with secretion modulated by gut hormones (incretins).
4. What remains unclear?
Exact basal insulin concentrations during fasts of different length were not extracted from the sources reviewed; it is also uncertain whether Elawady meant 'zero' literally or as 'very low'.
5. Which studies support it?
I-FAST-01 (insulin falls, ketones rise); partly I-FAST-05 (fasting insulin reduced in some trials; nothing supports insulin falling to zero).
6. Which studies contradict it?
7. What applies to Germany and Europe?
Not region-specific.
8. What is known about Egypt?
Not region-specific; Ramadan fasting practice is common.
9. What practical conclusion is appropriate?
Fasting lowers insulin, which is part of its metabolic effect, but a body without any insulin is in danger. People with diabetes on insulin must not stop basal insulin during fasting without medical advice.
Assessment details
- Rationale for certainty of evidence
It is well established that insulin falls during fasting while glucagon rises, enabling fat breakdown and ketone production (kernel correct). Basal insulin secretion continues in healthy people and is essential: complete absence of insulin (type 1 diabetes) leads to uncontrolled ketogenesis and DKA. ADA advises that people on intensive insulin therapy should not stop basal insulin even when not eating. Evidence is physiological and guideline-based; no direct study measuring 'zero' was reviewed (moderate).
- Source quality
Homepage editorial paraphrase plus own words in machine transcripts.
- Regional transferability
Universal.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
When we do not eat, insulin goes down and the body starts burning stored fat. That part is correct. But insulin never reaches zero in a healthy person, because a small amount is always needed to keep acids in the blood under control. When insulin really is missing, as in type 1 diabetes, life-threatening ketoacidosis follows.
Studies on this claim
Studies supporting the claim (1)
-
How the body fuels itself during starvation
Cahill GF. Annu Rev Nutr 2006 · PMID 16848698 · DOI 10.1146/annurev.nutr.26.061505.111258Narrative reviewindependent cross-checkabstract only checkedDuring long fasting the brain uses ketones from fat, which allows survival.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Fuel metabolism in prolonged starvation
- How was the study done?
Narrative/biographical review
- How many people, animals or samples were studied?
not applicable; Humans in starvation (historical studies)
- What was actually found?
Ketones fuel the brain in starvation.
- How large was the observed effect?
not reported
- What do the results mean in everyday life?
Fasting ketosis is normal physiology in healthy people.
- What are the study's limitations?
Narrative; No quantitative data in abstract
- What does it say about Elawady's specific claim?
Supports physiological kernels of C-FAST-01, C-FAST-03, C-FAST-04 (fasting ketosis is normal).
- Do the results apply to Germany and Europe?
Physiology universal.
- What can explicitly not be concluded from this study?
That high glucose plus ketones is harmless in diabetes.
No study in this group is marked as key.
Studies contradicting or limiting the claim (2)
-
Review on diabetic ketoacidosis
Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1Narrative reviewindependent cross-checkfull text checkedDKA is an emergency that can kill; it is treated with fluids, insulin and salts, and insulin must not be stopped in type 1 diabetes even when not eating.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Epidemiology, pathogenesis, diagnosis and management of DKA
- How was the study done?
Narrative expert review (Nature Reviews Disease Primers)
- How many people, animals or samples were studied?
not applicable; Adults and children with diabetes
- What was actually found?
DKA is diagnosed by high glucose, ketones and acid; it kills <1% when treated in rich countries but up to 26-41% where treatment is lacking; treatment is fluids, insulin and potassium, and insulin must never be stopped in type 1 diabetes even when not eating.
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
DKA is an emergency.
- What are the study's limitations?
Narrative expert review without systematic methods; one author has research support from insulin makers.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
International.
- What can explicitly not be concluded from this study?
Quantitative estimates.
-
ADA guideline 2026: blood sugar goals and emergencies
American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006Guideline / position statementindependent cross-checkfull text checked★ key studyMost adults should aim for HbA1c below 7%, avoid low sugar, and measure ketones when at risk.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Glycaemic goals, hypoglycaemia and hyperglycaemic crises
- How was the study done?
Clinical practice guideline (ADA Standards of Care 2026, Section 6)
- How many people, animals or samples were studied?
not applicable; People with diabetes
- What was actually found?
Individual targets; do not stop basal insulin when not eating.
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
Moderate targets and safety rules.
- What are the study's limitations?
US-centred; Partially read
- What does it say about Elawady's specific claim?
Supports C-INS-04, C-INS-11; contradicts C-FAST-01, C-FAST-03, C-DIAB-02.
- Do the results apply to Germany and Europe?
Consistent with EASD guidance.
- What can explicitly not be concluded from this study?
Not applicable.
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
What intermittent fasting does to metabolism
Patterson RE et al.. Annu Rev Nutr 2017 · PMID 28715993 · DOI 10.1146/annurev-nutr-071816-064634Narrative reviewindependent cross-checkfull text checkedFasting regimens seem to help weight loss and may improve metabolism; much is still hypothesis.
Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Metabolic effects of intermittent fasting
- How was the study done?
Narrative review
- How many people, animals or samples were studied?
not applicable; Humans and animal models
- What was actually found?
Most small fasting trials showed some weight loss; fasting was not better than eating less every day; benefits for liver and metabolism come mainly from mouse studies.
- How large was the observed effect?
not reported
- What do the results mean in everyday life?
A possible tool, not a cure.
- What are the study's limitations?
Not a systematic review; small, short human studies; much evidence from male mice; no long-term disease outcomes.
- What does it say about Elawady's specific claim?
Partial support for C-FAST-02, C-FAST-05; kernel of C-FAST-01.
- Do the results apply to Germany and Europe?
General.
- What can explicitly not be concluded from this study?
Superiority or detox effects.
No study in this group is marked as key.
Regional context
Germany / EU
Not region-specific.
Egypt
Not region-specific; Ramadan fasting practice is common.
What applies in my country?
General scientific assessment
Mostly false Fasting lowers insulin but does not and should not bring it to zero.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Fuel metabolism in starvation.. Cahill GF. Annu Rev Nutr 2006 · PMID 16848698 · DOI 10.1146/annurev.nutr.26.061505.111258
- Diabetic ketoacidosis.. Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1
- 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006
- Metabolic Effects of Intermittent Fasting.. Patterson RE et al.. Annu Rev Nutr 2017 · PMID 28715993 · DOI 10.1146/annurev-nutr-071816-064634